BioSpace News Archive

Immix Biopharma, Inc. today announced the IMMX Milestone Day Event, to be held on April 5, 2022.

Agile Therapeutics, Inc. today announced it will report fourth quarter and full year 2021 financial results after the market close on Wednesday, March 30, 2022.

Ventyx Biosciences, Inc. announced that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview at the Barclays Global Healthcare Conference being held March 15-17, 2022.

Brooklyn ImmunoTherapeutics, Inc. today announced that it has entered into a definitive agreement to sell securities in a private placement with a leading healthcare investor.

Hepion Pharmaceuticals, Inc. announced today that its CMO, Dr. Todd Hobbs, will present at the Q1 Investor Summit Conference on Wednesday, March 9, 2022 at 1:15 p.m. Eastern Time.

Alterity Therapeutics today announced that David Stamler , M.D., Chief Executive Officer will present a company update and participate in investor meetings at the 34th Annual Roth Conference.

Seelos Therapeutics, Inc. today announced its year-end 2021 business and clinical update.

Helio Health today announced that Hepatology Communications published positive results from the ENCORE study validating HelioLiver’s strong clinical performance in detecting the presence of early hepatocellular carcinoma.

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation, announced the publication of a new white paper entitled, “HPAPI Drug Solid Oral Dosage Manufacturing – Ensuring Content Uniformity.”

Acurx Pharmaceuticals, Inc. announced today that the Company will release its fourth quarter 2021 and fiscal year end 2021 financial results on Thursday, March 17, 2022, at 8:30 am ET before the U.S. financial markets open.